Daniel H. Solomon, MD, MPH, & Andrew Concoff, MD, FACR |
Over our 25 years as rheumatologists, care has advanced greatly. We each completed our rheumatology training in the late 1990s when both infliximab and etanercept first arrived on the U.S. market, ushering in the era of biologics in rheumatology. Since this time, our greater understanding of the immunologic basis of many rheumatic diseases has translated…
Lisa Christopher-Stine, MD, MPH, discussed the latest findings on myositis and its subtypes, including insights into antibodies linked to cancer and treatments for these patients.
ACR President Carol A. Langford, MD, MPH, highlights the importance of research in the field and where to find resources and initiatives within the ACR to support, fund, inspire, and enhance innovation. For more on this important topic, see Dr. Langford’s column in the January issue of The Rheumatologist.
Dr. Feely discusses his previous work with the College, his current work as a practicing rheumatologist and how he will lead continued advances on the insurance front.
Research & patients reap benefits when patients with rheumatic conditions get involved in patient-facing organizations & in clinical research planning.
Patients with RA not only suffer from functional limitations, but also face increased healthcare costs, primarily due to prescription drug use, says Dr. Yinan Huang.
We recently learned that Bruce McNeil Milburn, MD (70), passed away Dec. 27, 2024, from complications of amyotrophic lateral sclerosis (ALS). He was diagnosed with ALS just a year ago. Dr. Milburn was a practicing rheumatologist in Brevard County, Fla., for more than 30 years. Born on March 23, 1954, Dr. Milburn dedicated his life…
In this episode of his monthly video series for The Rheumatologist, physician editor Dr. Bharat Kumar talks about dreams—their importance and the role of the rheumatologist and rheumatology professionals in helping patients fulfill their dreams.